Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Soviredia vs Harvoni in Healthy Volunteers
NCT04039958Phase 1Completed
- Sponsor
- Genuine Research Center
- Start
- Apr 2017
- Primary completion
- May 2017
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in hepatitis C (HCV) (2 arms), sponsored by Genuine Research Center. Primary endpoints: Maximal measured plasma concentration up to 72 hours, Area under the concentration-time curve from time zero to the last measurable concentration up to 72 hours and 1 more. Started Apr 2017; status: completed.
02
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT04039958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04039958.